GLP‑1 guides and research
Plain answers on GLP-1 cost, compounded tirzepatide and semaglutide, dosing and safety, plus our own data on FDA warning letters. Every figure cites its source.
74 articles by the glp1.health team· Updated Nov 1, 2026· 3 medically reviewed by Angelica C. Marrero, MD· How we write and check
Start here
- 5
Step 5: Compare the programs
The full ranking, on prices read at each program’s checkout.
See the ranking
Ready to compare programs?
Our three top-rated programs. Prices updated November 3, 2026, each read at the program’s own checkout.
See the full rankingWe may earn a commission when you sign up through some links. It never changes our order or scores. How we make money
- 1$53/moVisit site of Embody
- 2$65/moVisit site of YourEra
- 3$76/moVisit site of Collective
Our data
- Research · Aug 16, 202643 of 100
registered 503B outsourcing facilities have never been inspected
8 min read
- Research · Aug 16, 202676 of 158
FDA warning letters naming a GLP-1 came in the last 12 months
26 min read
- Research · Aug 16, 202614 of 50
GLP-1 telehealth programs have received an FDA warning letter
5 min read
- Research · Aug 16, 2026$39.3 billion
Medicare spending on GLP-1 drugs: $39.3 billion gross in 2025 (preliminary)
6 min read
- Research · Sep 21, 2026$11.95 billion
Total reimbursed for Medicaid GLP-1 drugs in 2025: about $11.95 billion, before rebates. California paid $3.46 billion of it.
8 min read
- Research · Aug 16, 202640 of 103
GLP-1 packages have a federal acquisition cost, priced per pen
9 min read
- Research · Aug 16, 202611.0 million
State Medicaid programs reimbursed 11.0 million GLP-1 prescriptions in 2025
9 min read
All articles
Newest first
- Comparisons
Mounjaro vs Ozempic for Type 2 Diabetes: Results, Doses, Side Effects and Price
Mounjaro lowered blood sugar and weight more than Ozempic in the one head-to-head trial, SURPASS-2.
Gerard Fernandez · Oct 26, 2026 · 11 min read - Comparisons
Mounjaro vs Zepbound: The Same Tirzepatide, Two Labels, Two Prices
Yes, Mounjaro and Zepbound contain the same drug, tirzepatide, made by Eli Lilly, in the same doses from 2.5 mg to 15 mg a week.
Gerard Fernandez · Updated Oct 26, 2026 · 10 min read - Safety
503A vs 503B Pharmacies: What FDA's Inspection Record Shows
A 503A pharmacy compounds for one patient and answers mainly to its state board of pharmacy.
Gerard Fernandez · Oct 25, 2026 · 7 min read - Research
Average weight loss on GLP-1: two numbers from 12 trials
Average weight loss on a GLP-1 depends on the drug, the dose and who is counted.
Pierre Huchot · Oct 25, 2026 · 11 min read - Research
Retatrutide: How to Get It Legally, and the Sellers Google Cites
Retatrutide is not approved by any regulator in the world, and Lilly says it cannot be sold to consumers.
Pierre Huchot · Oct 25, 2026 · 9 min read - Guides
GLP-1 Price Tracker Review: How pricetrackerglp1.com Checks GLP-1 Prices
PriceTracker GLP-1 (pricetrackerglp1.com) is a free GLP-1 price tracker that reads 22 US telehealth programs from their own pages every week and ranks them by all-in monthly price, membership fees included.
Gerard Fernandez · Oct 22, 2026 · 7 min read - Guides
GLP-1 Watchdog Review: What glp1watchdog.com Does Well and Where It Stops
GLP-1 Watchdog (glp1watchdog.com) is a free site that compares 49 online GLP-1 providers by recorded price, plan terms, clinician claims and pharmacy information.
Gerard Fernandez · Oct 22, 2026 · 7 min read - Safety
Can You Drink Alcohol on a GLP-1? Wegovy, Ozempic, Zepbound and Mounjaro
No FDA label for Wegovy, Ozempic, Zepbound or Mounjaro bans alcohol or lists it as a drug interaction.
Gerard Fernandez · Oct 8, 2026 · 8 min read - How-to
Best Time of Day to Take Mounjaro, Zepbound, Wegovy and Ozempic
There is no best time of day to take Mounjaro, Zepbound, Wegovy or Ozempic injections: each FDA label says to inject once a week at any time of day, with or without meals.
Gerard Fernandez · Oct 8, 2026 · 7 min read - Safety
Compounded Semaglutide: Does It Work, Is It Safe, and Is It Still Legal?
Compounded semaglutide is a pharmacy-made version of the active ingredient in Ozempic and Wegovy, and it is not FDA-approved, so the FDA has not verified its safety, effectiveness or quality.
Medically reviewed by Angelica C. Marrero, MDGerard Fernandez · Updated Nov 1, 2026 · 16 min read - Safety
Compounded Tirzepatide: Is It Safe, Is It Legal, and What Changed?
Compounded tirzepatide is a pharmacy-made version of the active ingredient in Zepbound and Mounjaro, and it is not FDA-approved.
Medically reviewed by Angelica C. Marrero, MDGerard Fernandez · Updated Nov 1, 2026 · 16 min read - Cost
Does Insurance Cover Zepbound or Wegovy? How to Check in 2026
Insurance covers Zepbound or Wegovy only when your plan includes a weight-loss drug benefit and lists the drug on its formulary, usually with prior authorization.
Gerard Fernandez · Updated Oct 12, 2026 · 9 min read - Safety
Do GLP-1 Patches Work? What Patches and Supplements Can and Can't Do
No.
Gerard Fernandez · Oct 8, 2026 · 7 min read - Medications
Your First Weeks on a GLP-1: What to Expect on Zepbound and Wegovy
The first weeks on Zepbound or Wegovy are a low starting dose meant to let your body adjust.
Pierre Huchot · Oct 8, 2026 · 7 min read - Cost
How Much Do GLP-1s Cost Without Insurance in 2026?
Without insurance, a brand-name GLP-1 costs about $149 to $499 a month at manufacturer self-pay prices as of October 2026.
Gerard Fernandez · Updated Oct 26, 2026 · 10 min read - Medications
GLP-1 Microdosing: What It Is and What the Evidence Says
Microdosing a GLP-1 means taking less than the labeled dose, or spacing doses further apart than the label says, usually to reduce side effects or cost.
Pierre Huchot · Updated Oct 12, 2026 · 8 min read - Medications
GLP-1 Pills vs Injections: Do the Pills Work as Well as the Shots?
GLP-1 pills work, though the strongest injections still lead.
Pierre Huchot · Updated Oct 26, 2026 · 8 min read - Safety
GLP-1s, Pregnancy and Breastfeeding: Ozempic, Wegovy, Zepbound and Mounjaro
No GLP-1 is approved for use in pregnancy.
Gerard Fernandez · Oct 8, 2026 · 8 min read - How-to
Do Mounjaro, Zepbound, Wegovy and Ozempic Need to Be Refrigerated?
Yes.
Gerard Fernandez · Oct 8, 2026 · 7 min read - Safety
How Long Do Zepbound, Wegovy and Ozempic Stay in Your System?
Semaglutide, the drug in Wegovy and Ozempic, stays in circulation for about 5 to 7 weeks after the last dose, according to the Wegovy label.
Gerard Fernandez · Oct 8, 2026 · 7 min read - Medications
How Long Does Wegovy Take to Work? Wegovy, Ozempic and Semaglutide Timelines
Wegovy starts acting within days of the first injection, but weight loss builds over months.
Pierre Huchot · Oct 8, 2026 · 7 min read - Medications
How Long Does It Take for Zepbound to Work?
Zepbound starts acting within a day, but weight loss takes weeks and the full trial effect takes about a year and a half.
Pierre Huchot · Oct 8, 2026 · 7 min read - Access
How to Get Ozempic, Who Qualifies, and What Changes for Weight Loss
To get Ozempic, a licensed prescriber, in person or by telehealth, must judge it appropriate for you, and a state-licensed pharmacy must fill it.
Gerard Fernandez · Updated Oct 12, 2026 · 8 min read - Access
How to Get Wegovy: Online, With Insurance, or Self-Pay
To get Wegovy you need a prescription from a licensed clinician, in person or through a telehealth visit.
Gerard Fernandez · Updated Oct 12, 2026 · 7 min read - Access
How to Get Zepbound (Tirzepatide): Prescription, LillyDirect and Prices
To get Zepbound (tirzepatide), you need a prescription from a licensed clinician, in person or online, which you then fill at LillyDirect Pharmacy or another pharmacy.
Gerard Fernandez · Updated Oct 26, 2026 · 8 min read - Medications
How to Inject Mounjaro: Where to Inject, the Best Site, and Pen, KwikPen and Vial Steps
Mounjaro is injected under the skin once a week in the stomach or thigh, or in the back of the upper arm if another person injects.
Pierre Huchot · Oct 8, 2026 · 8 min read - How-to
How to Inject Ozempic and Wegovy, Where to Inject, and How to Store the Pens
Inject Ozempic or Wegovy under the skin of the abdomen, thigh or upper arm, once a week, rotating the exact spot each time.
Gerard Fernandez · Oct 8, 2026 · 10 min read - Medications
How to Inject Zepbound (Tirzepatide) With a Pen, KwikPen or Vial
Inject Zepbound under the skin of the abdomen or thigh, or have another person inject it into the back of the upper arm, choosing a different spot each week.
Pierre Huchot · Oct 8, 2026 · 9 min read - Cost
Does Medicare Cover Ozempic, Wegovy or Zepbound in 2026?
Partly.
Gerard Fernandez · Updated Oct 12, 2026 · 8 min read - Medications
Is Metformin a GLP-1? Metformin vs Ozempic, Wegovy and Mounjaro
Metformin is not a GLP-1.
Pierre Huchot · Oct 8, 2026 · 7 min read - Medications
Mounjaro Dosage: The Highest Dose, the Titration Schedule and How to Take It
The highest dose of Mounjaro is 15 mg injected once a week for adults, and 10 mg once a week for children 10 and older.
Pierre Huchot · Oct 8, 2026 · 8 min read - Safety
Mounjaro Side Effects: Hair Loss, Tiredness, Constipation and How Long They Last
Mounjaro's most common side effects are nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion and stomach pain.
Gerard Fernandez · Oct 8, 2026 · 7 min read - Medications
Why Am I Not Losing Weight on Wegovy, Ozempic, Mounjaro or Zepbound?
The most common reasons are a dose that is still being stepped up and a slower-than-average response.
Pierre Huchot · Updated Oct 12, 2026 · 8 min read - Safety
Ozempic Face: What It Is, What Causes It and How to Avoid It
Ozempic face is a popular, not medical, term for the gaunt look, sunken cheeks, wrinkles and loose skin that can follow rapid weight loss, including on GLP-1 drugs such as Ozempic, Wegovy and Zepbound.
Gerard Fernandez · Oct 8, 2026 · 6 min read - Safety
Ozempic Side Effects, From Tiredness and Hair Loss to the Boxed Warning
The most common Ozempic side effects are nausea, vomiting, diarrhea, abdominal pain and constipation, each reported in at least 5% of patients.
Gerard Fernandez · Oct 8, 2026 · 8 min read - Medications
Phentermine vs Ozempic and Wegovy: Is Phentermine a GLP-1?
No.
Pierre Huchot · Oct 8, 2026 · 7 min read - Medications
Retatrutide vs Tirzepatide: How "Reta" Compares With Zepbound and Mounjaro
Retatrutide produced more weight loss than tirzepatide in separate trials: 28.3% at 80 weeks on 12 mg in TRIUMPH-1, against 20.9% at 72 weeks on tirzepatide 15 mg.
Pierre Huchot · Updated Oct 25, 2026 · 7 min read - Safety
Semaglutide Units to mg: How Many mg Is 20, 40 or 50 Units of Semaglutide?
On a U-100 insulin syringe, 100 units equal 1 mL, so the mg in a dose depends on the vial's concentration.
Medically reviewed by Angelica C. Marrero, MDGerard Fernandez · Updated Nov 1, 2026 · 9 min read - Medications
Tirzepatide Pills: Is There an Oral Tirzepatide?
There is no FDA-approved tirzepatide pill.
Pierre Huchot · Updated Oct 12, 2026 · 6 min read - Safety
Tirzepatide Units to mg: How Many Units Is 2.5 mg, and How Many mg Is 20 or 40 Units?
The number of units in a tirzepatide dose depends on the concentration printed on the vial.
Gerard Fernandez · Oct 8, 2026 · 9 min read - Medications
Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In SURMOUNT-5, the only head-to-head trial in adults with obesity, tirzepatide produced more weight loss than semaglutide: an average of 20.2% of body weight against 13.7% over 72 weeks.
Pierre Huchot · Oct 8, 2026 · 10 min read - Medications
Wegovy Dosage: Every Dose, When to Increase, and the Highest Dose (Injection and Pill)
Increase the Wegovy injection every 4 weeks: 0.25 mg for weeks 1 to 4, then 0.5 mg, 1 mg and 1.7 mg, reaching the 2.4 mg maintenance dose at week 17.
Pierre Huchot · Oct 8, 2026 · 8 min read - Medications
Wegovy Pill vs Injection: Effectiveness, Doses, Cost and How to Take It
The Wegovy pill, oral semaglutide 25 mg taken once a day, produced weight loss close to the weekly injection: 13.6% at 64 weeks on the label, against 14.9% at 68 weeks for the 2.4 mg injection.
Pierre Huchot · Updated Oct 12, 2026 · 9 min read - Medications
What Is Foundayo? Lilly's Orforglipron Pill, Explained
Foundayo is orforglipron, a once-daily GLP-1 pill from Eli Lilly that the FDA approved on April 1, 2026, for weight loss in adults with obesity, or overweight plus a weight-related condition.
Pierre Huchot · Updated Oct 26, 2026 · 8 min read - Science
What Is GLP-1? The Hormone, the Medications and How They Work
GLP-1, or glucagon-like peptide-1, is a gut hormone released after eating that raises insulin, lowers glucagon, slows the stomach and reduces appetite.
Pierre Huchot · Oct 8, 2026 · 8 min read - Medications
What Is Ozempic? How Semaglutide Works, What It Treats and What It Isn't
Ozempic is the brand name for semaglutide, a prescription GLP-1 receptor agonist made by Novo Nordisk and injected once a week.
Pierre Huchot · Oct 8, 2026 · 9 min read - Medications
What Is Zepbound? How Tirzepatide Works, Who It's For and How Safe It Is
Zepbound is the brand name for tirzepatide, a once-weekly injection from Eli Lilly that activates both GIP and GLP-1 receptors.
Pierre Huchot · Oct 8, 2026 · 8 min read - Lifestyle
What to Eat on a GLP-1: Foods to Favor and Avoid on Zepbound, Wegovy and Ozempic
On a GLP-1 such as Zepbound, Wegovy or Ozempic, the 2025 joint nutrition advisory recommends minimally processed foods built around vegetables, fruits, whole grains, legumes, lean proteins, nuts and seeds, in regular small meals.
Gerard Fernandez · Oct 8, 2026 · 8 min read - Access
Who Qualifies for Ozempic, Wegovy or Zepbound? BMI Rules and Prescriptions
Wegovy and Zepbound are FDA-approved for weight reduction in adults with a BMI of 30 or more, or 27 or more with at least one weight-related condition.
Gerard Fernandez · Oct 8, 2026 · 7 min read - Medications
Zepbound Dosage: Every Dose, the Step-Up Schedule and Which Dose Works Best
Zepbound starts at 2.5 mg once weekly for 4 weeks, then rises to 5 mg and can increase in 2.5 mg steps after at least 4 weeks on each dose, up to a 15 mg maximum.
Pierre Huchot · Oct 8, 2026 · 8 min read - Cost
Zepbound Savings Card and Coupons in 2026, Explained
The Zepbound savings card cuts the price to as little as $25 a fill, but only for people whose commercial insurance covers Zepbound, and it excludes Medicare, Medicaid and other government programs.
Gerard Fernandez · Updated Oct 26, 2026 · 10 min read - Safety
Zepbound Side Effects: How Common They Are, How Long They Last, and the Serious Warnings
The most common Zepbound side effects are gastrointestinal: in the label's pooled trials, 56% of people on each dose had one, against 30% on placebo.
Gerard Fernandez · Oct 8, 2026 · 8 min read - Medications
Zepbound for Sleep Apnea: FDA Approval, How It Works and Insurance Coverage
Yes.
Pierre Huchot · Oct 8, 2026 · 7 min read - Medications
Zepbound Weight Loss Results: How Much You Can Lose in 3 Months, a Year and Beyond
In the main Zepbound trial, SURMOUNT-1, adults without diabetes lost an average of 15.0% of body weight on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg after 72 weeks, against 3.1% on placebo.
Pierre Huchot · Oct 8, 2026 · 7 min read - Safety
Wegovy Side Effects: Tiredness, Hair Loss, Nausea and How Long They Last
Wegovy's most common side effects are gastrointestinal, led by nausea in 44% of adults on the 2.4 mg injection, against 16% on placebo.
Gerard Fernandez · Oct 8, 2026 · 8 min read - Guides
Retatrutide Dose: What the Trials Used, 1 mg to 12 mg a Week
Retatrutide has no approved dose, and the FDA says it has not been found safe and effective for any condition.
Gerard Fernandez · Oct 7, 2026 · 4 min read - Guides
Tirzepatide Dosing (Zepbound, Mounjaro): 2.5 mg to 15 mg, From the FDA Labels
Tirzepatide (Zepbound, Mounjaro) is injected once a week, starting at 2.5 mg weekly for 4 weeks.
Gerard Fernandez · Oct 6, 2026 · 6 min read - Science
Is Wegovy an Appetite Suppressant? What the Lost Weight Is Made Of, From STEP 1 and STEP 6
Yes, as its FDA label describes it: Wegovy's effects are likely mediated by affecting appetite, and semaglutide decreases calorie intake and delays gastric emptying.
Pierre Huchot · Oct 5, 2026 · 4 min read - Cost
What Health Insurance Covers Zepbound? Medicare's $50 Bridge Runs Through 2027
Zepbound coverage depends on the payer.
Gerard Fernandez · Updated Oct 12, 2026 · 5 min read - Comparisons
Wegovy vs Zepbound: Side-Effect Rates From the Two FDA Labels
On the FDA labels, Wegovy reports higher rates of the common stomach side effects than Zepbound: nausea in 44% of adults on Wegovy 2.4 mg against 25% to 29% on Zepbound 5 mg to 15 mg.
Gerard Fernandez · Updated Oct 5, 2026 · 6 min read - Comparisons
Foundayo vs Tirzepatide (Zepbound): Weight Loss at Each Dose, From Both FDA Labels
Tirzepatide (Zepbound) caused more weight loss than Foundayo (orforglipron) at every dose, in separate placebo trials.
Gerard Fernandez · Updated Oct 5, 2026 · 6 min read - Research
Total reimbursed for Medicaid GLP-1 drugs in 2025: about $11.95 billion, before rebates. California paid $3.46 billion of it.
The total reimbursed for Medicaid GLP-1 drugs in 2025 was about $11.95 billion, according to CMS State Drug Utilization Data.
Pierre Huchot · Updated Oct 25, 2026 · 8 min read - Mental health
GLP-1s and Your Brain: Depression, Cravings, and "Ozempic Personality"
GLP-1 drugs reduce cravings and do not raise suicide risk.
Gerard Fernandez · Aug 31, 2026 · 5 min read - Safety
The Hidden Cost of Fast Weight Loss: Muscle and Bone on GLP-1s
Fast weight loss on a GLP-1 takes muscle and bone as well as fat.
Gerard Fernandez · Aug 31, 2026 · 5 min read - Medications
Is There a "GLP-3"? What People Actually Mean (Retatrutide, Explained)
There is no GLP-3.
Pierre Huchot · Updated Oct 25, 2026 · 4 min read - Science
What Is Food Noise? And Why GLP-1s Switch It Off
Food noise is persistent, intrusive thinking about food that the person experiences as unwanted and disruptive to daily life, as defined in a 2025 study.
Pierre Huchot · Aug 31, 2026 · 4 min read - Research
56 of 57 inspected 503B facilities received a Form 483
When the FDA inspects a 503B outsourcing facility, it nearly always issues a Form 483: 56 of 57 facilities with an inspection date on the FDA's 503B register had one, or 98.2%, on the register as of November 17, 2026.
Pierre Huchot · Updated Oct 25, 2026 · 10 min read - Research
43 of 100 registered 503B outsourcing facilities have never been inspected
43 of the 100 outsourcing facilities registered with the FDA under section 503B, or 43.0%, had no inspection date on the FDA's register as of November 17, 2026.
Pierre Huchot · Updated Oct 25, 2026 · 8 min read - Research
40 of 103 GLP-1 packages have a federal acquisition cost, priced per pen
Only 40 of the 103 GLP-1 packages in the FDA National Drug Code directory have a CMS acquisition cost (NADAC) that resolves to a price per package.
Pierre Huchot · Updated Oct 7, 2026 · 9 min read - Research
Only 24 of 42 GLP-1 telehealth programs ship to all 50 states
Only 24 of 42 online GLP-1 programs tracked on this site ship to all 50 US states, verified program by program from each provider's own published coverage.
Pierre Huchot · Updated Oct 24, 2026 · 6 min read - Research
14 of 50 GLP-1 telehealth programs have received an FDA warning letter
14 of the 50 online GLP-1 telehealth programs tracked here, or 28.0%, had received an FDA warning letter as of October 27, 2026: Belle, Direct Meds, Eden Health GLP-1, Hers, Hims, LevelsRx, LumiMeds, Maximus Tribe, MEDVi, Remedy Meds, SkinnyRx, Sprout Health, Strut Health and VivioMD, with letters from September 2025 to June 2026.
Pierre Huchot · Updated Oct 24, 2026 · 5 min read - Research
76 of 158 FDA warning letters naming a GLP-1 came in the last 12 months
76 of the 158 FDA warning letters whose text names a GLP-1 medication were issued in the last 12 months, as of November 21, 2026.
Pierre Huchot · Updated Oct 24, 2026 · 26 min read - Research
State Medicaid programs reimbursed 11.0 million GLP-1 prescriptions in 2025
Medicaid programs in the 50 states and DC reimbursed 10,994,383 GLP-1 prescriptions in 2025, with $11.89 billion in total reimbursement, according to CMS State Drug Utilization Data.
Pierre Huchot · Updated Oct 25, 2026 · 9 min read - Research
Medicare spending on GLP-1 drugs: $39.3 billion gross in 2025 (preliminary)
Medicare Part D recorded $39.3 billion in gross spending on GLP-1 drugs in 2025 (preliminary), before rebates.
Pierre Huchot · Updated Oct 25, 2026 · 6 min read